Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| NSI-189 | Pramiracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 40 mg once daily (for educational context — investigational compound, not approved for any indication) | 400-1200 mg/day divided into 2-3 doses |
| Timing | Once daily, time of day not definitively established from clinical data. With or without food. | With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred. |
| Cycle Duration | Phase 2 trial used 12-week treatment duration. Long-term safety data unavailable. | Cycles of 8-12 weeks on, 4 weeks off |
| Evidence Level | moderate_human | moderate_human |
Benzylpiperizine-aminopyridine compound that stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and increases hippocampal volume in vivo. Mechanism is independent of serotonin or norepinephrine reuptake inhibition — fundamentally distinct from traditional antidepressants. Activates the TrkB receptor (BDNF receptor) and downstream Akt/PI3K signaling pathways to promote synaptic plasticity, long-term potentiation, and neuronal survival. Enhances BDNF expression in hippocampal subregions critical for memory consolidation and mood regulation. Originally developed as ALTO-100 (Alto Neuroscience) for treatment-resistant depression with cognitive impairment.
40 mg once daily (for educational context — investigational compound, not approved for any indication)
Once daily, time of day not definitively established from clinical data. With or without food.
Phase 2 trial used 12-week treatment duration. Long-term safety data unavailable.
Potently stimulates high-affinity choline uptake (HACU) in hippocampal synaptosomes, the rate-limiting step in acetylcholine synthesis. This profoundly enhances cholinergic neurotransmission without direct receptor agonism. Approximately 10-30x more potent than piracetam on a per-milligram basis. Does not significantly affect other neurotransmitter systems, making it a highly targeted cholinergic enhancer.
400-1200 mg/day divided into 2-3 doses
With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred.
Cycles of 8-12 weeks on, 4 weeks off
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →